Literature DB >> 4344209

Failure of a 3-substituted triazinoindole in the prevention of experimental human rhinovirus infection.

Y Togo, A R Schwartz, R B Hornick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4344209     DOI: 10.1159/000221243

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  5 in total

1.  Evaluation of isoprinosine in experimental human rhinovirus infection.

Authors:  D M Pachuta; Y Togo; R B Hornick; A R Schwartz; S Tominaga
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

2.  Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challenge.

Authors:  Y Togo; F E Durr; D A Laurenzana
Journal:  Med Microbiol Immunol       Date:  1977-05-18       Impact factor: 3.402

3.  Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection.

Authors:  Y Togo; A R Schwartz; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

Review 4.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

Review 5.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.